Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS    
Revenue $ 5,678 $ 47,601
Operating expenses    
Research and development (35,207) (25,548)
General and administrative (19,732) (20,397)
Total operating expenses (54,939) (45,945)
Operating (loss)/profit (49,261) 1,656
Interest income 1,345 676
Other income (expense), net (61) (671)
(Loss)/profit before income tax expense (47,977) 1,661
Income tax expense (526) (625)
Net (loss)/profit attributable to ordinary shareholders $ (48,503) $ 1,036
Net (loss)/profit attributable to ordinary shareholders    
Basic (in dollars per share) $ (0.03) $ 0.00
Diluted (in dollars per share) $ (0.03) $ 0.00
Weighted average shares outstanding:    
Basic (in shares) 1,451,241,661 991,330,402
Diluted (in shares) 1,451,241,661 1,000,276,615